Pherentasin is the only pressor substance found in blood of hypertensive patients which is not found in normal blood. This study defines its unit and compares its concentration with diastolic blood pressure level, type of hypertension, and age of patients. Lack of correlation between blood pressure level and pherentasin content suggests considerable variation in the amount of depressor substances in these patients. Chemical studies of pherentasin and its partial, tentative formula are discussed. Demonstration of the existence of an additional pressor fraction from blood which is volatile in alkaline solution is described. This work was done under a grant-in-aid from the National Heart Institute, United States Public Health Service. 380 quently found in the renal than in the neurogenic or endocrine types of hypertension raises the question of the relative concentrations which will be observed.
Pherentasin is the only pressor substance found in blood of hypertensive patients which is not found in normal blood. This study defines its unit and compares its concentration with diastolic blood pressure level, type of hypertension, and age of patients. Lack of correlation between blood pressure level and pherentasin content suggests considerable variation in the amount of depressor substances in these patients. Chemical studies of pherentasin and its partial, tentative formula are discussed. Demonstration of the existence of an additional pressor fraction from blood which is volatile in alkaline solution is described. P HERENTASIN, a pressor substance present in the arterial blood of hypertensive, but not of normotensive, patients, was demonstrated by Stock and Schroeder,' and confirmed by Olsen and Schroeder.2 Its occurrence in different types of hypertension was reported by Schroeder and Olsen.3 The present report concerns quantitative studies and chemical properties of the substance discovered during further purification of the concentrated extracts used for assay in the previous investigation,2 and the data on 50 cases subsequently studied.
QUANTITATION BY ASSAY

Definition of a Unit of Pherentasin
We suspected that the criteria initially used for the rat pressor assay to establish the existence of pherentasin were unnecessarily rigid.3 Analysis of the data demonstrated this to be true. Furthermore, attempts to isolate and identify the material, which were limited by a purely qualitative test for its presence or abstnce, would be expedited by an estimate of the amount in each fraction. In addition, the preliminary finding that pherentasin is more fre-quently found in the renal than in the neurogenic or endocrine types of hypertension raises the question of the relative concentrations which will be observed.
Therefore, a statistical analysis of the responses of the diastolic blood pressure of hypertensive rats to the injection of extracts of normotensive human arterial blood has been made. The first step involved a demonstration of the lack of delayed pressor effect from depressor substances (of the adenine series2) present in the extracts. Obviously a pressor reaction caused by anoxia consequent to hypotension would invalidate the method as a means of assay of pressor substances. As shown in figure 1, immediate depressor responses were not correlated with the delayed pressor effect of pherentasin. By definition3 the extract has not been considered positive unless diastolic pressure was elevated at least 12 mm. Hg 10, 15, or 20 minutes after injection. Measurements at these intervals were used in the analysis.
Close examination of the effects on blood pressure of the injection of normotensive and hypertensive extracts into rats showed that false positive responses did not occur, while false negative responses in single tests were not uncommon. Whether or not failure to respond to the pressor substance was due to too deep anesthesia, a refractory stage of hypertension of individual rats, or greater sensitivity of a particular rat to counteracting depressor contaminants in the extract is not known. How-ever, the degree of depression of blood pressure in the false negative assays was not significant, and they were considered as assays with zero rather than a negative pressor response in the analysis.
The unit is defined as the amount of pherentasin present in an extract of 20 ml. of blood which will, in at least three assays on three renal hypertensive rats, produce an average maximum elevation of diastolic blood pressure at 10, 15 or 20 minutes after injection exceeding Figure 2 shows that there was no correlation between diastolic blood pressure of hypertensive patients and the amount of pherentasin found in their blood. While elevation of diastolic blood pressure was limited to a twofold increase over normal values, the observed concentration of pherentasin ranged from less than 1 to 7 units. CHEMICAL STUDIES Three types of extracts were studied. Extracts of hypertensive blood which proved to be pressor in the rat were pooled and designated "active extract." Hypertensive extracts which were not pressor were called "inactive extract." All blood was treated in the same way except for 520 ml. of the first "normal" pool which was obtained from the blood bank. These pooled fractions will be discussed under the appropriate headings.
Preliminary Tests
Because of the paucity of active material in blood, microchemical technics were used initially to determine whether or not primary amine groups were present. The color reaction with ninhydrin was positive in both test tube and spot tests on paper. Single dimensional paper chromatography was carried out according to the method of Williams and Kirby.4
When 0.167 ml. of the active extract was run in a phenol-water bath, three spots appeared on spraying with a solution of ninhydrin specially developed for amines.7 When 0.334 ml. of extract was run in a butanol-water solvent, five spots developed. Several repetitions of this procedure showed the presence of eight amino nitrogen compounds from butanol-water chromatograms and six from phenol chromatograms (table 2) . Two-dimensional chromatography, * using collidine and lutidine for one direction and phenol-water for the second, was carried out on 1.0 ml. and resulted in 10 ninhydrinsensitive spots. Their positions on the paper gave presumptive evidence for the presence of seven amino acids, histamine and two unidentified substances. (fig. 4) . Of the latter, one of the substances barely moved and had an Rf value in the range of histamine, histidine, arginine, and lysine. The second amino compound found in the eluate gave a distinct blue color after spraying and had an Rf of 0.62. As indicated elsewhere7 this finding strongly suggests the presence of a 5 to 7 carbon aliphatic moiety but does not rule out a ring structure. However, it favors the absence of phenolic groups in this substance, since all phenolic amines tried have given a yellow to brownish hue. Evidence that this substance may be an abnormal metabolite of at least the renal type of hypertension was obtained when a pool of similarly prepared extracts of normotensive individuals was treated in a similar manner. The only ninhydrin-sensitive substance found was the one with the low Rf value. Identification of the rapidly moving substance with pherentasin is still lacking, although the eluate from IRC-50 was positive in the rat mesoappendix test (table 3) .
The presence of a ninhydrin-sensitive compound with an Rf of 0.64 in the filtrate of the inactive pool may be evidence for incomplete uptake by the Amberlite IRC-50 resin. This would not be surprising, since very weak bases are taken up poorly by Amberlite IRC-50. The absence of a ninhydrin spot on the phenolwater chromatogram of the eluate of this sepaamounts as to give a negative pressor test. On the other hand, another vasoexcitor which does not necessarily have an effect on blood pressure may be invariably present when pherentasin is present and frequently when it is not. The latter seems unlikely. Figure 5 shows the results of fractionations and assay procedures on the active and inactive Pherentasin may be present in such small pools of hypertensive blood. The mesoappendix test was positive in both pools. It was also positive in the active eluate and was negative in the inactive filtrate. The filtrate of one treatment of the active pool was negative, but was positive after another treatment. This difference may have been caused by incomplete ion exchange in the latter case.
Absorption Spectra. The ultraviolet absorption spectrum of the active pool indicated peaks at 273 and 320 mm., the absorption densities of which were greatly reduced in an Amberlite IRC-50 eluate of the pool. Figure 6 shows the absorption in the visible range of the color complex formed between ninhydrin and concentrates of pherentasin; isopropanol and 90 per cent ethanol were used as solvents for pherentasin. The pherentasin-ninhydrin solution in isopropanol was slightly turbid and the second peak of the ninhydrin-amine complex (520 ,g) occurred at a wave length well below the lowest present in the amines of biologic interest chosen for study.7 The turbidity was only partially corrected by using 90 per cent ethanol as solvent. Ultraviolet spectra and those of the ninhydrin complex of highly con-centrated extracts of pherentasin showed definite differences from comparable absorption curves made for methy amine, ethylamine, butylamine, isoamylamine, tyramine, tryptamine, histamine, arterenol, and phenethylamine.
Electron Diffraction. One-tenth ml. of the oil fraction referred to previously2 was chromatographed in a butanol-water solvent. On spraying with ninhydrin a spot with an Rf of 0.042 developed, indicating histamine or one of the amino acids. A solution of the crystals* was chromatographed on paper in a butanol-water solvent. A narrow vertical strip was cut from the paper along the edge of the pherentasin "crystal extract." A large spot appeared at an was cut into 12 squares, the lowest being larger than the rest to accommodate the area apparently taken by the amino compound. Each was made into a mash and eluted with three times normal hydrochloric acid, evaporated to a few drops and dried in a vacuum desiccator.
The eluate from the Rf fraction from 0.0 to 0.15 was photographed under the electron diffraction beam of an RCA model electron microscope on the chance of obtaining additional information on the chemical groups present in the material which does not move in butanol-water. Distinct rings observable in the diffraction patterns of the sample were not present in the collodion blank. The ring diameters did not Although more pherentasin is usually present in the blood of the renal group, the wide variability of levels requires a larger sampling before significant differences can be established. The neurogenic component, therefore, does not account for the lack of correlation between pherentasin and blood pressure. (b) Variations in the amount of depressor contaminants in the extracts, large enough to mask the concentrations of pherentasin, are an unlikely explanation when such a routine procedure is used. (c) Similarly it is impossible that destruction or loss of the active principle could occur in some of the extractions without occurring in all. The sevenfold range of concentrations of pherentasin observed at the same level of diastolic blood pressure makes any interpretation difficult to accept, other than that there are variable amounts of depressor material in the circulating blood. The possibility remains that pherentasin has a linear relationship with diastolic blood pressure below a certain threshold of nearly maximal effect on arterioles. It will be noted from the case of rheumatic heart disease with mitral stenosis and cardiac decompensation that factors leading to the production of pherentasin can be present without an elevated blood pressure. Other normotensive subjects, however, have been shown to have neither pressor nor vasoexcitor substance in their extracts.3 The two exceptions were in febrile states. Until its final identification is accomplished, chemical determination of the concentration of pherentasin in blood will not be feasible. Efforts in this direction are now in progress. SUMMARY 1. Pherentasin, a pressor substance present in human arterial hypertensive blood, has been separated as a base from a number of amino acid and other contaminants.
2. Its partial tentative formula is proposed.
3. The unit of pherentasin is defined statistically and quantitative estimates of its concentration in blood are correlated with various clinical parameters. 4 . Evidence for the existence of a volatile pressor substance distinct from pherentasin in arterial blood of hypertensive patients is presented.
